A detailed history of Ameriprise Financial Inc transactions in Glaukos Corp stock. As of the latest transaction made, Ameriprise Financial Inc holds 1,640,165 shares of GKOS stock, worth $248 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,640,165
Previous 1,343,300 22.1%
Holding current value
$248 Million
Previous $159 Million 34.41%
% of portfolio
0.06%
Previous 0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$113.62 - $135.39 $33.7 Million - $40.2 Million
296,865 Added 22.1%
1,640,165 $214 Million
Q2 2024

Aug 14, 2024

SELL
$89.48 - $118.35 $10.4 Million - $13.7 Million
-116,159 Reduced 7.96%
1,343,300 $159 Million
Q1 2024

May 15, 2024

BUY
$76.4 - $96.33 $24.7 Million - $31.1 Million
322,774 Added 28.4%
1,459,459 $138 Million
Q4 2023

Feb 14, 2024

BUY
$59.53 - $85.11 $16.7 Million - $23.9 Million
280,524 Added 32.77%
1,136,685 $90.4 Million
Q3 2023

Nov 14, 2023

BUY
$69.23 - $79.09 $18.6 Million - $21.2 Million
268,280 Added 45.64%
856,161 $64.4 Million
Q2 2023

Aug 14, 2023

BUY
$45.44 - $71.21 $18.6 Million - $29.2 Million
409,566 Added 229.69%
587,881 $41.9 Million
Q1 2023

May 15, 2023

SELL
$43.88 - $52.48 $272,056 - $325,376
-6,200 Reduced 3.36%
178,315 $8.93 Million
Q4 2022

Feb 14, 2023

SELL
$40.82 - $57.75 $409,628 - $579,521
-10,035 Reduced 5.16%
184,515 $8.06 Million
Q3 2022

Nov 14, 2022

SELL
$46.84 - $58.49 $202,817 - $253,261
-4,330 Reduced 2.18%
194,550 $10.4 Million
Q2 2022

Aug 15, 2022

SELL
$34.86 - $63.77 $206,684 - $378,092
-5,929 Reduced 2.89%
198,880 $9.03 Million
Q1 2022

May 16, 2022

SELL
$44.33 - $57.82 $4.44 Million - $5.79 Million
-100,178 Reduced 32.85%
204,809 $11.8 Million
Q4 2021

Feb 14, 2022

SELL
$40.27 - $56.99 $10.9 Million - $15.5 Million
-271,886 Reduced 47.13%
304,987 $13.6 Million
Q3 2021

Nov 15, 2021

SELL
$47.43 - $84.23 $20.4 Million - $36.2 Million
-429,361 Reduced 42.67%
576,873 $27.8 Million
Q2 2021

Aug 16, 2021

BUY
$73.06 - $97.7 $19.8 Million - $26.5 Million
271,243 Added 36.9%
1,006,234 $85.4 Million
Q1 2021

May 17, 2021

BUY
$70.43 - $97.42 $10.2 Million - $14.2 Million
145,288 Added 24.64%
734,991 $61.7 Million
Q4 2020

Feb 12, 2021

BUY
$48.9 - $75.26 $1.6 Million - $2.46 Million
32,661 Added 5.86%
589,703 $44.4 Million
Q3 2020

Nov 16, 2020

BUY
$37.23 - $50.97 $586,074 - $802,369
15,742 Added 2.91%
557,042 $27.6 Million
Q2 2020

Aug 14, 2020

BUY
$28.78 - $46.83 $2.92 Million - $4.75 Million
101,502 Added 23.08%
541,300 $20.8 Million
Q1 2020

May 15, 2020

BUY
$25.53 - $70.14 $4.47 Million - $12.3 Million
174,945 Added 66.05%
439,798 $13.6 Million
Q4 2019

Feb 14, 2020

BUY
$54.18 - $65.64 $959,473 - $1.16 Million
17,709 Added 7.17%
264,853 $14.4 Million
Q3 2019

Nov 14, 2019

BUY
$58.58 - $83.91 $6.92 Million - $9.91 Million
118,068 Added 91.47%
247,144 $15.4 Million
Q2 2019

Aug 14, 2019

SELL
$63.59 - $78.71 $5.84 Million - $7.23 Million
-91,902 Reduced 41.59%
129,076 $9.73 Million
Q1 2019

May 15, 2019

SELL
$50.75 - $80.54 $2.57 Million - $4.08 Million
-50,599 Reduced 18.63%
220,978 $17.3 Million
Q4 2018

Feb 14, 2019

BUY
$52.18 - $67.93 $1.47 Million - $1.92 Million
28,263 Added 11.62%
271,577 $15.3 Million
Q3 2018

Nov 14, 2018

BUY
$38.13 - $68.37 $3.33 Million - $5.96 Million
87,214 Added 55.87%
243,314 $15.3 Million
Q2 2018

Aug 14, 2018

BUY
$27.62 - $44.51 $148,512 - $239,330
5,377 Added 3.57%
156,100 $6.35 Million
Q1 2018

May 15, 2018

BUY
$26.05 - $34.5 $1.54 Million - $2.03 Million
58,935 Added 64.21%
150,723 $4.65 Million
Q4 2017

Feb 12, 2018

SELL
$24.5 - $36.01 $247,866 - $364,313
-10,117 Reduced 9.93%
91,788 $2.36 Million
Q3 2017

Nov 07, 2017

BUY
$31.26 - $42.03 $3.19 Million - $4.28 Million
101,905
101,905 $3.36 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.2B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.